Completed

Oral Supplement for Hormonal Imbalance Relief

What is being tested

Perelel Health Hormonal Balance Support

Dietary Supplement

Who is being recruted

Over 18 Years

+12 Eligibility Criteria

See all eligibility criteria

How is the trial designed

Treatment Study

Interventional

Study Start: February 2024

See protocol details

Summary

Principal SponsorPerelel Inc.

Last updated: January 28, 2026

Sourced from a government-validated database.Claim as a partner

Study start date: February 19, 2024

Actual date on which the first participant was enrolled.

This study is designed to explore how an oral supplement from Perelel Health can help alleviate symptoms associated with hormonal imbalances and improve overall menstrual health. The focus is on individuals who experience discomfort or issues due to hormonal fluctuations. By understanding the supplement's effect, the study aims to find new ways to support those struggling with hormonal imbalance, potentially offering a natural and effective solution. Participants in this study will take the oral supplement for a period of 12 weeks. The study is conducted virtually, meaning participants can join from their own homes without needing to visit a clinic. Researchers will monitor changes in symptoms related to hormonal imbalance and menstrual health to determine the supplement's effectiveness. While the primary outcomes or specific measurements are not detailed, the study seeks to gather insights into the supplement's impact on overall well-being during the trial period.

Official TitleA Single-Group Clinical Trial to Evaluate the Effect of an Oral Supplement to Provide Relief From Symptoms of Hormonal Imbalance.

NCT06535698

Principal SponsorPerelel Inc.

Last updated: January 28, 2026

Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.

Design Details

35 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Treatment Study

These studies test new ways to treat a disease, condition, or health issue. The goal is to see if a new drug, therapy, or approach works better or has fewer side effects than existing options.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.

Criteria

Female

Biological sex of participants that are eligible to enroll.

Over 18 Years

Range of ages for which participants are eligible to join.

Healthy volunteers allowed

If individuals who are healthy and do not have the condition being studied can participate.

Criteria

4 inclusion criteria required to participate

Self-reported symptoms of hormonal imbalance (e.g., mood swings, irregular menstrual cycles)

Generally healthy without uncontrolled chronic diseases

Willing to avoid new hormonal balance treatments during the study

Consistent use of current hormonal balance treatments for at least 3 months prior to the study

8 exclusion criteria prevent from participating

Chronic conditions preventing adherence to the protocol Diabetes

Planned hormonal balance-related procedures during the study

Started any new medications or supplements that target hormonal balance in the past 3 months

Anyone with diabetes

Show More Criteria

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.

Treatment Groups

Study Objectives

One single intervention group is designated in this study

This study does not include a placebo group

Treatment Groups

Group I

Experimental

Participants in this arm will receive Perelel Health hormonal balance support capsules. The dosage regimen is as follows: Week 1: 1 capsule daily in the evening Week 2: 2 capsules daily in the evening Weeks 3-12: 4 capsules daily (2 in the morning and 2 in the evening) The supplement contains Myo-inositol (1000 mcg), Metabolic balance blend (200 mcg) including Berberine HCl, Alpha lipoic acid, DIM (33'-Diindolylmethane), and D-chiro-inositol (25 mg). Other ingredients include Vegetable cellulose (capsule), plant cellulose, and L-leucine.

Study Objectives

Primary Objectives

Secondary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

Suspended

Citruslabs

Santa Monica, United StatesOpen Citruslabs in Google Maps

CompletedOne Study Center